Research Paper Volume 2, Issue 11 pp 823—842
A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction
- 1 Molecular Biotechnology Center and Department of Genetics, Biology and Biochemistry, University of Turin, Via Nizza 52, 10126 Turin, Italy
- 2 Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy
- 3 Nencki Institute of Experimental Biology, Department of Biochemistry, Warsaw, Poland
- 4 Preclinical Imaging Center c/o Center of Molecular Biotechnologies, Bioindustry Park, Colleretto Giacosa, Turin, Italy
- 5 Department of Pathology and New York University Cancer Institute, New York, NY 10016, USA
- 6 Department of Molecular Biology and Microbiology, University of Central Florida, Orlando, FL 32826, USA
- 7 Department of Pathology, University of Cambridge, Cambridge, UK
Received: November 10, 2010 Accepted: November 14, 2010 Published: November 15, 2010
https://doi.org/10.18632/aging.100232How to Cite
Abstract
The pro-oncogenic transcription factor STAT3 is constitutively activated in a wide variety of tumours that often become addicted to its activity, but no unifying view of a core function determining this widespread STAT3-dependence has yet emerged. We show here that constitutively active STAT3 acts as a master regulator of cell metabolism, inducing aerobic glycolysis and down-regulating mitochondrial activity both in primary fibroblasts and in STAT3-dependent tumour cell lines. As a result, cells are protected from apoptosis and senescence while becoming highly sensitive to glucose deprivation. We show that enhanced glycolysis is dependent on HIF-1α up-regulation, while reduced mitochondrial activity is HIF-1α-independent and likely caused by STAT3-mediated down-regulation of mitochondrial proteins. The induction of aerobic glycolysis is an important component of STAT3 pro-oncogenic activities, since inhibition of STAT3 tyrosine phosphorylation in the tumour cell lines down-regulates glycolysis prior to leading to growth arrest and cell death, both in vitro and in vivo. We propose that this novel, central metabolic role is at the core of the addiction for STAT3 shown by so many biologically different tumours.